KA
ABBV icon

KDT Advisors’s AbbVie ABBV Stock Holding History

KDT Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Sell
1,027
-830
-45% -$184K 0.36% 69
2025
Q4 		$424K Buy
1,857
+40
+2% +$9.11K 0.6% 51
2025
Q3 		$421K Sell
1,817
-1,202
-40% -$245K 0.62% 48
2025
Q2 		$560K Hold
3,019
– – 0.9% 32
2025
Q1 		$633K Hold
3,019
– – 0.93% 35
2024
Q4 		$536K Buy
+3,019
New +$555K 0.79% 41

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KDT Advisors's ABBV Position: Q1 2026 in Review

KDT Advisors reduced its AbbVie (ABBV) stake by 45% in Q1 2026, selling an estimated $184K and leaving 1,027 shares worth $223K. The position accounts for 0.36% of the portfolio, ranked #69.

KDT Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $633K in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • KDT Advisors held 1,027 shares of AbbVie worth $223K as of Q1 2026.
  • KDT Advisors sold 830 AbbVie shares in Q1 2026, an estimated $184K.
  • AbbVie made up 0.36% of KDT Advisors's portfolio in Q1 2026, its #69 holding.
  • KDT Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • KDT Advisors's AbbVie position peaked at $633K in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on KDT Advisors's 13F filing for Q1 2026, filed 15 May 2026.